Kairos Pharma (KAPA) Cash From Operations

Annual CFO

$81.00 K
+$434.00 K+122.95%

December 1, 2023


Summary


Performance

KAPA Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKAPAcash flowmetrics:

Quarterly CFO

-$2.02 M
-$1.85 M-1102.38%

September 30, 2024


Summary


Performance

KAPA Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKAPAcash flowmetrics:

TTM CFO

-$2.09 M
-$2.11 M-8444.00%

September 30, 2024


Summary


Performance

KAPA TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKAPAcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

KAPA Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+123.0%-3160.6%-2675.3%
3 y3 years+310.4%-1264.9%-1309.5%
5 y5 years+310.4%-1264.9%-1309.5%

KAPA Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+119.7%-2319.8%at low-1768.8%at low
5 y5-yearat high+119.7%-2319.8%at low-1768.8%at low
alltimeall timeat high+119.7%-2319.8%at low-1768.8%at low

Kairos Pharma Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$2.02 M(+1102.4%)
-$2.09 M(-8444.0%)
Jun 2024
-
-$168.00 K(-566.7%)
$25.00 K(-80.0%)
Mar 2024
-
$36.00 K(-45.5%)
$125.00 K(+54.3%)
Dec 2023
$81.00 K
$66.00 K(-27.5%)
$81.00 K(-250.0%)
Sep 2023
-
$91.00 K(-233.8%)
-$54.00 K(-72.6%)
Jun 2023
-
-$68.00 K(+750.0%)
-$197.00 K(-7.5%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$8000.00(-88.4%)
-$213.00 K(-39.7%)
Dec 2022
-$353.00 K(-14.3%)
-$69.00 K(+32.7%)
-$353.00 K(+24.3%)
Sep 2022
-
-$52.00 K(-38.1%)
-$284.00 K(+22.4%)
Jun 2022
-
-$84.00 K(-43.2%)
-$232.00 K(+56.8%)
Mar 2022
-
-$148.00 K
-$148.00 K
Dec 2021
-$412.00 K(+970.1%)
-
-
Dec 2020
-$38.50 K
-
-

FAQ

  • What is Kairos Pharma annual cash flow from operations?
  • What is the all time high annual CFO for Kairos Pharma?
  • What is Kairos Pharma annual CFO year-on-year change?
  • What is Kairos Pharma quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Kairos Pharma?
  • What is Kairos Pharma quarterly CFO year-on-year change?
  • What is Kairos Pharma TTM cash flow from operations?
  • What is the all time high TTM CFO for Kairos Pharma?
  • What is Kairos Pharma TTM CFO year-on-year change?

What is Kairos Pharma annual cash flow from operations?

The current annual CFO of KAPA is $81.00 K

What is the all time high annual CFO for Kairos Pharma?

Kairos Pharma all-time high annual cash flow from operations is $81.00 K

What is Kairos Pharma annual CFO year-on-year change?

Over the past year, KAPA annual cash flow from operations has changed by +$434.00 K (+122.95%)

What is Kairos Pharma quarterly cash flow from operations?

The current quarterly CFO of KAPA is -$2.02 M

What is the all time high quarterly CFO for Kairos Pharma?

Kairos Pharma all-time high quarterly cash flow from operations is $91.00 K

What is Kairos Pharma quarterly CFO year-on-year change?

Over the past year, KAPA quarterly cash flow from operations has changed by -$2.09 M (-3160.61%)

What is Kairos Pharma TTM cash flow from operations?

The current TTM CFO of KAPA is -$2.09 M

What is the all time high TTM CFO for Kairos Pharma?

Kairos Pharma all-time high TTM cash flow from operations is $125.00 K

What is Kairos Pharma TTM CFO year-on-year change?

Over the past year, KAPA TTM cash flow from operations has changed by -$2.17 M (-2675.31%)